Pictet Asset Management (Switzerland)’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $18.4M | Buy |
2,741,086
+856,846
| +45% | +$5.75M | 0.02% | 489 |
|
2023
Q1 | $16.6M | Buy |
1,884,240
+1,251,512
| +198% | +$11.1M | 0.02% | 500 |
|
2022
Q4 | $4.83M | Buy |
632,728
+158,695
| +33% | +$1.21M | 0.01% | 743 |
|
2022
Q3 | $3.38M | Buy |
474,033
+178,651
| +60% | +$1.27M | 0.01% | 815 |
|
2022
Q2 | $2.39M | Buy |
295,382
+150,154
| +103% | +$1.21M | ﹤0.01% | 909 |
|
2022
Q1 | $2.02M | Hold |
145,228
| – | – | ﹤0.01% | 957 |
|
2021
Q4 | $4.08M | Sell |
145,228
-431,472
| -75% | -$12.1M | ﹤0.01% | 874 |
|
2021
Q3 | $19.6M | Buy |
+576,700
| New | +$19.6M | 0.02% | 515 |
|